Detailed Information on Publication Record
2022
PMVEMA-coated upconverting nanoparticles for upconversion-linked immunoassay of cardiac troponin
SHAPOVAL, Oleksandr, Julian BRANDMEIER, Mykhailo NAHORNIAK, Viktoriia OLEKSA, Ekaterina MAKHNEVA et. al.Basic information
Original name
PMVEMA-coated upconverting nanoparticles for upconversion-linked immunoassay of cardiac troponin
Authors
SHAPOVAL, Oleksandr (804 Ukraine), Julian BRANDMEIER (276 Germany, belonging to the institution), Mykhailo NAHORNIAK (804 Ukraine), Viktoriia OLEKSA (804 Ukraine), Ekaterina MAKHNEVA (643 Russian Federation, belonging to the institution), Hans-Heiner GORRIS (276 Germany, belonging to the institution), Zdeněk FARKA (203 Czech Republic, guarantor, belonging to the institution) and Daniel HORÁK
Edition
Talanta, Elsevier, 2022, 0039-9140
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
10406 Analytical chemistry
Country of publisher
Netherlands
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 6.100
RIV identification code
RIV/00216224:14310/22:00125622
Organization unit
Faculty of Science
UT WoS
000793049100006
Keywords in English
Photon-upconversion nanoparticle; Poly(methyl vinyl ether‐alt‐maleic acid);Bioconjugation; Immunoassay; Upconversion-linked immunosorbent assay; Cardiac troponin I
Tags
Tags
International impact, Reviewed
Změněno: 23/6/2022 13:06, Mgr. Marie Šípková, DiS.
Abstract
V originále
Surface engineering of upconverting nanoparticles (UCNPs) is crucial for their bioanalytical applications. Here, an antibody specific to cardiac troponin I (cTnI), an important biomarker for acute myocardial infection, was covalently immobilized on the surface of UCNPs to prepare a label for the detection of cTnI biomarker in an upconversion-linked immunoassay (ULISA). Core-shell UCNPs (NaYF4:Yb,Tm@NaYF4) were first coated with poly(methyl vinyl ether‐alt‐maleic acid) (PMVEMA) and then conjugated to antibodies. The morphology (size and uniformity), hydrodynamic diameter, chemical composition, and amount of coating on the of UCNPs, as well as their upconversion luminescence, colloidal stability, and leaching of Y3+ ions into the surrounding media, were determined. The developed ULISA allowed reaching a limit of detection (LOD) of 0.13 ng/ml and 0.25 ng/ml of cTnI in plasma and serum, respectively, which represents 12- and 2-fold improvement to conventional enzyme-linked immunosorbent based on the same immunoreagents.
Links
GA21-03156S, research and development project |
| ||
LQ1601, research and development project |
| ||
LTAB19011, research and development project |
|